Position in ADCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$25,721
+$1,509 QoQ
Shares Held
6,859
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Ameritas Investment Partners, Inc. holds $15,281,212 across 38 Drug Manufacturers - Specialty & Generic names. ADCT ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
7,932 | $4,703,517 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,489 | $2,435,740 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
91,533 | $2,190,384 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
17,594 | $1,334,504 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
55,114 | $1,144,166 | |
| 6 | ALKS |
Alkermes plc.
|
13,171 | $465,726 | |
| 7 | ZTS |
Zoetis Inc.
|
3,786 | $447,543 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
9,848 | $300,167 |
All Filings in ADCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,721 | 6,859 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $24,212 | 6,859 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $27,436 | 6,859 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $18,382 | 6,859 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $9,671 | 6,859 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $13,649 | 6,859 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $21,605 | 6,859 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $21,674 | 6,859 | Shares | Other | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||